Physician profile
Pravati Das
NPI 1548475999
$691.87
in general payments reported to CMS, 2019-2025
16 companies · $22.38 in 2025
The $22.38 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $61.01 · 2021: $18.75 · 2022: $52.72 · 2023: $68.93 · 2024: $73.72 · 2025: $22.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116 · Education: $49.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.81 |
| Education | $49.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $109.03 | 2019 | |
| Fresenius USA Marketing, INC. | $94.86 | 2019-2023 | Velphoro |
| Merck Sharp & Dohme LLC | $74.98 | 2021-2025 | Verquvo |
| Vifor Pharma, INC. | $66.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $62.00 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $50.73 | 2019 | |
| Akebia Therapeutics INC | $49.22 | 2024 | Vafseo |
| Amgen INC. | $27.24 | 2019 | |
| Shire North American Group INC | $24.57 | 2019 | |
| Medtronic, INC. | $24.50 | 2024 | Intellis Adaptivestim |
| Genentech USA, INC. | $23.05 | 2019 | |
| Mallinckrodt Hospital Products INC. | $20.35 | 2020 | |
| Pfizer INC. | $19.89 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.26 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.89 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pravati Das listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.